Is the era of Big Pharma outsourcing ending? See why the tide is turning against CROs.

Big Pharma is reaching a critical inflection point in how it manages clinical trials. While larger entities have historically relied on Contract Research Organizations for operational support, the current landscape suggests a strategic shift back toward in-house management. Frustrations regarding inefficiencies, particularly with site payments and administrative delays, are driving companies to rethink their dependency on external partners. When controlling these functions internally becomes economically advantageous, the traditional model of outsourcing faces significant scrutiny and potential obsolescence.
#BigPharma #ClinicalTrials #PharmaceuticalIndustry #CRO #BusinessStrategy #HealthcareInnovation

Видео Is the era of Big Pharma outsourcing ending? See why the tide is turning against CROs. канала Dan Sfera